Lyndra Therapeutics said today that it raised $55 million in a Series B round to support the development of its oral drug delivery system.
All of the investors from the company’s $23 million Series A round resubscribed for the Series B round, Lyndra reported. New investors included the Bill & Melinda Gates Foundation.
Get the full story at our sister site, Drug Delivery Business News.
The post Lyndra raises $55m for long-acting drug delivery capsule appeared first on MassDevice.